144 related articles for article (PubMed ID: 18370212)
21. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
22. [Studies of mouse interleukin-2 gene therapy for head, and neck sequamous cell carcinoma using polycationic liposome-mediated transduction].
Yang H; Liu S; Liang C; Peng W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):9-11, 30. PubMed ID: 15600166
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration.
Anwer K; Kao G; Proctor B; Anscombe I; Florack V; Earls R; Wilson E; McCreery T; Unger E; Rolland A; Sullivan SM
Gene Ther; 2000 Nov; 7(21):1833-9. PubMed ID: 11110415
[TBL] [Abstract][Full Text] [Related]
24. Factor IX gene therapy for hemophilia.
Fewell JG
Methods Mol Biol; 2008; 423():375-82. PubMed ID: 18370215
[TBL] [Abstract][Full Text] [Related]
25. [IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma].
Liu S; Lin Y; Tang S; Yang H; Liang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Jun; 19(3):191-3. PubMed ID: 12539412
[TBL] [Abstract][Full Text] [Related]
26. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.
Duan X; Jia SF; Koshkina N; Kleinerman ES
Cancer; 2006 Mar; 106(6):1382-8. PubMed ID: 16453328
[TBL] [Abstract][Full Text] [Related]
27. Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site.
Ajiki T; Murakami T; Kobayashi Y; Hakamata Y; Wang J; Inoue S; Ohtsuki M; Nakagawa H; Kariya Y; Hoshino Y; Kobayashi E
Cancer Gene Ther; 2003 Apr; 10(4):318-29. PubMed ID: 12679805
[TBL] [Abstract][Full Text] [Related]
28. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma.
Xian J; Yang H; Lin Y; Liu S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1079-85. PubMed ID: 16365221
[TBL] [Abstract][Full Text] [Related]
29. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
30. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment.
Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
J Control Release; 2005 Jan; 101(1-3):273-85. PubMed ID: 15588911
[TBL] [Abstract][Full Text] [Related]
31. Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.
Li S; Zhang L; Torrero M; Cannon M; Barret R
Mol Ther; 2005 Nov; 12(5):942-9. PubMed ID: 15953768
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.
Cutrera J; Torrero M; Shiomitsu K; Mauldin N; Li S
Methods Mol Biol; 2008; 423():319-25. PubMed ID: 18370210
[TBL] [Abstract][Full Text] [Related]
33. Delivery of DNA into bladder via electroporation.
Yoshida M; Iwashita H; Otani M; Masunaga K; Inadome A
Methods Mol Biol; 2008; 423():249-57. PubMed ID: 18370204
[TBL] [Abstract][Full Text] [Related]
34. Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice.
Mandpe AH; Tsung K; Norton JA
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):786-92. PubMed ID: 12874083
[TBL] [Abstract][Full Text] [Related]
35. Gene delivery to dystrophic muscle.
Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
[TBL] [Abstract][Full Text] [Related]
36. KGF-1 for wound healing in animal models.
Marti GP; Mohebi P; Liu L; Wang J; Miyashita T; Harmon JW
Methods Mol Biol; 2008; 423():383-91. PubMed ID: 18370216
[TBL] [Abstract][Full Text] [Related]
37. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
[TBL] [Abstract][Full Text] [Related]
38. rIL-18 triggered gene therapy based on a transduction with the IL-12 plasmid: a new option as immuno-therapy for osteosarcoma?
Liebau C; Merk H; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Baltzer AW
Anticancer Res; 2002; 22(5):2559-65. PubMed ID: 12529964
[TBL] [Abstract][Full Text] [Related]
39. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor gene therapy for hypertension.
Komamura K; Miyazaki J; Imai E; Matsumoto K; Nakamura T; Hori M
Methods Mol Biol; 2008; 423():393-404. PubMed ID: 18370217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
